首页> 外国专利> METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HYPERPLASIA, INTRAEPITHELIAL NEOPLASIAS AND CERVIX UTERI CANCER

METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HYPERPLASIA, INTRAEPITHELIAL NEOPLASIAS AND CERVIX UTERI CANCER

机译:增生,上皮内淋巴结增生和宫颈癌的鉴别诊断方法

摘要

FIELD: medicine.;SUBSTANCE: the present innovation refers to the methods of cytological diagnostics. Smears obtained out of cervix uteri canal should be dyed with nuclear dye to be then studied upon a computed analyzer. On the image obtained it is necessary to measure the area of the nuclei of normal and tumor cells to establish their average values, moreover, the average value of the area of the nuclei of normal cells should be considered to be the standard. Then one should determine the multiplicity of excessive average value of the nuclei of tumor cells against the standard and at the value of this parameter ranged 1.1-1.4 times - one should diagnose hyperplasia, at 1.5-1.9 times - cervical intraepithelial neoplasia degree I (benign stage of carcinogenesis), at 2.0-2.4 times - cervical intraepithelial neoplasia stage II (boundary stage of carcinogenesis), and at its value being 2.5 and higher - cervix uteri cancer (malignant stage of carcinogenesis). The innovation enables to carry out accurate objective differential diagnostics of carcinogenesis stages in cervix uteri upon any cytological preparations.;EFFECT: higher accuracy and efficiency of diagnostics.;2 ex
机译:领域:医学。;物质:本发明涉及细胞学诊断方法。从子宫颈管获得的涂片应用核染料染色,然后在计算机分析仪上进行研究。在获得的图像上,必须测量正常细胞和肿瘤细胞的核面积以建立它们的平均值,此外,正常细胞的核面积的平均值应视为标准。然后,应确定肿瘤细胞核相对于标准的平均值的多重性,并且该参数的值范围为1.1-1.4倍-应诊断为1.5-1.9倍的增生-宫颈上皮内瘤变I(良性)癌变阶段),在2.0-2.4倍-宫颈上皮内瘤变阶段II(癌变的边界阶段),其值为2.5或更高-子宫颈子宫癌(癌变的恶性阶段)。这项创新技术可以对任何细胞学制剂进行宫颈癌发生阶段的准确客观的鉴别诊断。效果:诊断的准确性和效率更高; 2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号